MCRB
USDSeres Therapeutics Inc. Common Stock
$13.750-1.380 (-9.121%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$15.130
High
$15.340
Low
$13.750
Volume
0.08M
Company Fundamentals
Market Cap
120.4M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.16M
Exchange
NMS
Currency
USD
52-Week Range
Low $6.53Current $13.750High $24.665
Related News
GlobeNewswire
Seres Therapeutics Receives Award of Up to $3.6 Million from CARB-X to Develop Liquid Formulation of SER-155
CAMBRIDGE, Mass., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (NASDAQ:MCRB), a leading live biotherapeutics company, today announced that CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical
View more
GlobeNewswire
Seres Therapeutics to Present New Post Hoc Data From SER-155 Phase 1b Trial at IDWeek 2025, Highlighting Potential to Improve Outcomes in Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplant
CAMBRIDGE, Mass., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (NASDAQ:MCRB), (Seres or the Company), a leading live biotherapeutics company, today announced that new post hoc data from its SER-155 Phase
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.